G1 Therapeutics, Inc. 10-Q and 10-Q/A reports

Location
700 Park Offices Drive, Suite 200, Research Triangle Park, North Carolina
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
6/25/2024, 01:21 AM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q May 1, 2024 Mar 31, 2024
10-Q Report | Data 10-Q Nov 1, 2023 Sep 30, 2023
10-Q Report | Data 10-Q Aug 2, 2023 Jun 30, 2023
10-Q Report | Data 10-Q May 3, 2023 Mar 31, 2023
10-Q Report | Data 10-Q Nov 2, 2022 Sep 30, 2022
10-Q Report | Data 10-Q Aug 3, 2022 Jun 30, 2022
10-Q Report | Data GTHX-Q1-2022 10-Q May 4, 2022 Mar 31, 2022
10-Q Report | Data GTHX-Q3-2021 10-Q Nov 3, 2021 Sep 30, 2021
10-Q Report | Data GTHX-Q2-2021 10-Q Aug 4, 2021 Jun 30, 2021
10-Q Report | Data GTHX-Q1-2021 10-Q May 5, 2021 Mar 31, 2021
10-Q Report | Data GTHX-Q3-2020 10-Q Nov 4, 2020 Sep 30, 2020
10-Q Report | Data GTHX-Q2-2020 10-Q Aug 5, 2020 Jun 30, 2020
10-Q Report | Data GTHX-Q1-2020 10-Q May 6, 2020 Mar 31, 2020
10-Q Report | Data Q3 2019 10-Q Nov 5, 2019 Sep 30, 2019
10-Q Report | Data 10-Q Aug 7, 2019 Jun 30, 2019
10-Q Report | Data GTHX-Q1-2019 10Q May 9, 2019 Mar 31, 2019
10-Q Report | Data GTHX-Q3-2018 10-Q Nov 7, 2018 Sep 30, 2018
10-Q Report | Data 10-Q 6.30.2018 Aug 8, 2018 Jun 30, 2018
10-Q Report | Data GTHX Q1 2018 10-Q May 3, 2018 Mar 31, 2018
10-Q Report | Data 10-Q Nov 8, 2017 Sep 30, 2017
10-Q Report | Data 10-Q Aug 9, 2017 Jun 30, 2017